Can temporary tooth splinting improve healing after gum surgery in patients with severe gum disease?
| ISRCTN | ISRCTN12669458 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN12669458 |
| Sponsor | Victor Babeș University of Medicine and Pharmacy Timișoara |
| Funder | “Victor Babeș” University of Medicine and Pharmacy, Timișoara |
- Submission date
- 13/02/2026
- Registration date
- 17/02/2026
- Last edited
- 17/02/2026
- Recruitment status
- Not yet recruiting
- Overall study status
- Ongoing
- Condition category
- Oral Health
Plain English summary of protocol
Background and study aims
Severe gum disease (Stage IV periodontitis) can lead to major loss of bone around the teeth. In some patients, the lower front teeth become loose and uncomfortable, especially during chewing. Even after thorough cleaning below the gums, surgery is sometimes still needed to treat deep pockets that remain.
When teeth are already loose, their movement during healing may influence how well the surgical treatment works. One possible way to improve stability is to temporarily join the lower front teeth together with a thin metal wire bonded to the inner surfaces. This type of splint is commonly used in clinical practice to reduce mobility and improve comfort, but there is limited evidence about whether placing it before surgery improves healing results.
The main goal is to see whether splinting increases the number of treated sites that heal to shallow pocket depths without bleeding.
Who can participate?
Adult patients with advanced gum disease who require surgery in the lower front teeth and have at least one mobile tooth.
What does the study involve?
In this study, participants will be randomly assigned to one of two groups. One group will receive a temporary splint one week before surgery. The other group will undergo the same surgery without splinting. All patients will receive identical surgical care and follow-up.
Participants will be monitored for six months. We will also assess changes in gum measurements, tooth mobility, patient comfort, and, in the splinted group, how well the splint performs.
What are the possible benefits and risks of participating?
The findings may help determine whether temporary stabilization before surgery improves outcomes in patients with advanced periodontal disease.
Risks not provided at time of registration
Where is the study run from?
University Clinic of Periodontology, “Victor Babeș” University of Medicine and Pharmacy, Romania.
When is the study starting and how long is it expected to run for?
February 2027 to March 2028.
Who is funding the study?
University Clinic of Periodontology, “Victor Babeș” University of Medicine and Pharmacy, Romania.
Who is the main contact?
Dr Alla Belova, alla.belova@umft.ro
Contact information
Principal investigator, Scientific, Public
University Clinic of Periodontology
“Victor Babeș” University of Medicine and Pharmacy, Timișoara
bd. Revoluției din 1989 nr. 9
Timisoara
300041
Romania
| 0009-0005-0206-9110 | |
| Phone | +40740554557 |
| alla.belova@umft.ro |
Study information
| Primary study design | Interventional | |
|---|---|---|
| Allocation | Randomized controlled trial | |
| Masking | Blinded (masking used) | |
| Control | Historical | |
| Assignment | Parallel | |
| Purpose | Treatment | |
| Participant information sheet | 49029_PIS.pdf | |
| Scientific title | Effect of temporary composite-bonded wire splinting on the proportion of sites reaching therapeutic endpoints after surgical Step 3 of periodontal therapy in advanced (stage IV) periodontitis patients: a randomized controlled trial | |
| Study acronym | SPLINT-PERIO | |
| Study objectives | To evaluate whether temporary lingual composite-bonded eight-strand braided wire splinting of the intact mandibular anterior teeth (3.3–4.3) with hypermobility due to advanced periodontitis, placed prior to surgical Step 3 of periodontal therapy, increases the proportion of sites that reach therapeutic endpoints (PD ≤ 4 mm and no BOP) at 24 weeks post-operatively, compared with no splinting. Secondary aims include evaluating changes in probing depth, bleeding on probing and changes in clinical attachment, reductions in post-operative mobility, and patient-reported outcomes. | |
| Ethics approval(s) |
Approved 08/02/2026, The Ethical Committee of Scientific Research of “Victor Babeș” University of Medicine and Pharmacy, Timișoara (Str. Ciresului nr. 1A, Timisoara, 300610, Romania; +407256466001; enache.alexandra@umft.ro), ref: 09/02.08.2026 | |
| Health condition(s) or problem(s) studied | Treatment of Stage IV periodontitis in adults with hypermobile mandibular anterior teeth undergoing Step 3 periodontal surgery. | |
| Intervention | Test Group Protocol Participants in the test group will undergo seven scheduled visits throughout the study period. At Visit 1 (baseline), conducted after completion of the Step 2 periodontal treatment, a comprehensive periodontal evaluation will be performed. During this visit, participants will receive oral hygiene instructions (OHI), undergo professional mechanical plaque removal (PMPR), and complete patient-reported outcome measures (PROMs). One week prior to the scheduled surgery (Visit 1a), participants in the test group will receive lingual splint placement according to their randomization assignment, allowing for patient adaptation to the splint before the surgical intervention. Visit 3 will consist of PROMs collection, followed, during the same appointment, by periodontal surgery as clinically indicated. The surgical procedures will be performed according to standard protocols, with the pre-placed lingual splint remaining in situ to provide stabilization during the healing phase. Post-operative follow-up will begin at Visit 4, scheduled 2 weeks after surgery, during which sutures will be removed, gentle ultrasonic supragingival debridement will be performed, antiseptic irrigations will be administered, and splint integrity will be verified. Subsequent follow-up visits will occur at 8 weeks (Visit 5), 16 weeks (Visit 6), and 24 weeks (Visit 7) post-surgery. Each of these visits will include periodontal re-evaluation, collection of PROMs, PMPR, and splint integrity checks. The final visit (Visit 7) will additionally involve splint removal and assessment for potential replacement of the temporary splint with a permanent one, determined by the clinical outcomes observed during re-evaluation. Control Group Protocol Patients in the control group will be evaluated according to the six-visit schedule. Visit 1 (baseline) will be identical to the test group, including a comprehensive periodontal evaluation after Step 2 treatment completion, OHI, PMPR, and PROMs collection. In the control group, periodontal surgery (Step 3) will be performed at Visit 2 without prior splint placement, representing the standard treatment approach. Post-operative care in the control group will mirror the test group timeline at corresponding time points. Visit 4 (2 weeks post-surgery) will include suture removal, gentle ultrasonic supragingival debridement, and antiseptic irrigations, but without splint-related assessments. Follow-up visits at 8 weeks (Visit 5), 16 weeks (Visit 6), and 24 weeks (Visit 7) post-surgery each will comprise periodontal re-evaluation, PROMs collection, and PMPR. Probing depth (PD) and bleeding on probing (BOP) will be assessed at six sites per tooth (mesiobuccal, mid-buccal, distobuccal, mesiolingual, mid-lingual, distolingual) in teeth 3.3–4.3 using a UNC-15 periodontal probe (Hu-Friedy, Chicago, IL, USA) with standardized probing force (~0.25 N). Bleeding is recorded if present within 10 seconds after probing. The percentage of sites achieving PD ≤4 mm and absence of BOP at 24 weeks post-operatively will be calculated per patient. | |
| Intervention type | Procedure/Surgery | |
| Primary outcome measure(s) |
| |
| Key secondary outcome measure(s) |
| |
| Completion date | 03/03/2028 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 18 Years |
| Upper age limit | 100 Years |
| Sex | All |
| Target sample size at registration | 44 |
| Key inclusion criteria | 1. Age ≥ 18 years 2. Diagnosis of Stage IV periodontitis, according to the 2018 classification, all grades 3. Intact mandibular anterior region (teeth 3.3–4.3) 4. Presence of at least one tooth in the 3.3–4.3 region with a mobility degree of II or III (Miller’s classification) 5. Patients who underwent step 2 of periodontal therapy and are scheduled for surgical step 3 for not having reached the therapeutic endpoints in the intact mandibular anterior region (teeth 3.3–4.3) |
| Key exclusion criteria | 1. Inadequate oral hygiene following Step 2 of therapy (Full-mouth plaque score > 25%) 2. Systemic diseases or medical conditions known to affect periodontal healing 3. Presence of infrabony defects deeper than 4mm in 3.3 – 4.3 region; such defects, treatable by regenerative approaches, would preclude the patients to comply with the scheduled follow-up visits of the experiment 4. Smoking >10 cigarettes/day 5. Allergy to latex and any known sensitivity to the dental materials employed |
| Date of first enrolment | 14/02/2027 |
| Date of final enrolment | 31/12/2027 |
Locations
Countries of recruitment
- Romania
Study participating centres
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not expected to be made available |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Other files | Romanian | 13/02/2026 | No | No | |
| Other files | 17/02/2026 | No | No | ||
| Participant information sheet | Romanian | 13/02/2026 | No | Yes | |
| Participant information sheet | 17/02/2026 | No | Yes | ||
| Protocol file | English | 13/02/2026 | No | No |
Additional files
- 49029_PIS.pdf
- Romanian
- 49029_Consent form.pdf
- Romanian
- 49029_Protocol.pdf
- English
- 49029_Informed consent form English.pdf
- Other files
- 49029_PIS English.pdf
- Participant information sheet
Editorial Notes
17/02/2026: Study’s existence confirmed by the Ethical Committee of Scientific Research of “Victor Babeș” University of Medicine and Pharmacy, Timișoara, Romania.